Sirona Biochem Profit Margin

Sirona Biochem posts a profit margin of 16294.87% as of July 2024. That compares with -2696.95% in the prior-year period — up 704.2% year over year. That is above the Healthcare sector average of 9.71%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Sirona Biochem's profit margin was -2696.95%. The latest reading is 16294.87% — a 704.2% year-over-year increase (period ending July 2024). Use the history and growth charts on this page for a longer lookback.

For Healthcare stocks, a profit margin near 9.71% is typical. Sirona Biochem's 16294.87% is higher that level. That is roughly 167784.6% above the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Sirona Biochem's profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is 16294.87% as of July 2024; use YoY and peer views to separate noise from signal.

Context for SRBCF's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 9.71%), and (3) consistency with growth and profitability. This page covers the first two; Sirona Biochem's other metric pages and overview cover the third.